Format

Send to

Choose Destination
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39. doi: 10.1016/j.echo.2014.07.012.

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Author information

1
Cleveland Clinic, Cleveland, Ohio.
2
Federico II University Hospital, Naples, Italy.
3
Medstar Washington Hospital Center, Washington, District of Columbia.
4
MD Anderson Cancer Center, University of Texas, Houston, Texas.
5
University of Pennsylvania, Philadelphia, Pennsylvania.
6
Massachusetts General Hospital, Boston, Massachusetts.
7
McMaster University, Hamilton, Ontario, Canada.
8
Jewish General Hospital and McGill University, Montreal, Quebec, Canada.
9
University of Padua, Padua, Italy.
10
European Institute of Oncology, Milan, Italy.
11
Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania.
12
University of Chicago Medicine, Chicago, Illinois.
13
Oslo University Hospital and University of Oslo, Oslo, Norway.
14
Temple University, Philadelphia, Pennsylvania.
15
University of Liege, Liege, Belgium.
16
Memorial Sloan-Kettering Cancer Center, New York, New York.
17
Santa Marie University Hospital, Lisbon, Portugal.
18
Menzies Research Institute Tasmania, Hobart, Australia.
19
CNR Institute of Clinical Physiology, Pisa, Italy.
20
Mayo Clinic, Rochester, Minnesota.

KEYWORDS:

Biomarkers; Chemotherapy; Doxorubicin; Early detection; Left ventricular dysfunction; Strain; Three-dimensional echocardiography; Trastuzumab

PMID:
25172399
DOI:
10.1016/j.echo.2014.07.012
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science Icon for ORBi (University of Liege)
Loading ...
Support Center